About Neursantys
With offices in Chicago, Illinois and Calgary, Alberta, Neursantys creates innovative wearable diagnostic and therapeutic devices that expand access to comprehensive personalized diagnoses and treatments for people with balance disruptions caused by aging, injuries, or disease.
Neursantys is supported by a well-established network of R&D, manufacturing, clinical pilot, and business development partners in the U.S., Canada, the U.K., and Europe.
Contact Us
Our Team
Neursantys is led by an accomplished team of IoT device and data platform engineers, clinical neurology researchers and practitioners, and digital healthcare business professionals, with extensive experience launching, growing, and exiting innovative enterprises in healthcare and related technology markets.
John Ralston
PhD, MBA – CEO & Founder
- 2016 “Pioneer in Healthcare Technology Innovations Award”
- CEO, Sales & Marketing, R&D at 8 Silicon Valley companies (2 IPOs, 8 M&A exits)
- BSc MIT, PhD Cornell, MBA/MOT MIT Sloan
Josh Roper
VP Operations & Co-founder
- Seasoned IoT and SW engineer, product manager, business unit executive
- Previously Silver Spring Networks, SAP, Oracle, Portera, TXU
- BS EE, Rice University. MBA, UC Berkeley, Haas School of Business.
Josh Roper
VP Operations & Co-founder
- Seasoned IoT and SW engineer, product manager, business unit executive
- Previously Silver Spring Networks, SAP, Oracle, Portera, TXU
- BS EE, Rice University. MBA, UC Berkeley, Haas School of Business.
Ryan Peters
PhD – Chief Science Officer
- Faculty of Kinesiology and Human Performance Lab, University of Calgary
- Recognized expert in neural basis of human movement, EVS
- BA, PhD , Neuroscience & Behaviour, McMaster University.
Prentice Tom
MD – Chief Medical Officer
- Experienced physician executive, Chief Medical Officer, and Chief Innovation Officer
- BA Biophysics/Medical Physics, UC Berkeley. MD, Harvard Medical School. Intern and Resident, Johns Hopkins Medical Center. Kaiser Fellow, Health Policy and Management, MIT.
Prentice Tom
MD – Chief Medical Officer
- Experienced physician executive, Chief Medical Officer, and Chief Innovation Officer
- BA Biophysics/Medical Physics, UC Berkeley. MD, Harvard Medical School. Intern and Resident, Johns Hopkins Medical Center. Kaiser Fellow, Health Policy and Management, MIT.
Mary Furlong
CEO and Founder, Mary Furlong & Associates
- Industry-leading consultant helping corporations, technology innovators develop and implement commercial strategies in the healthcare and longevity marketplace.
- Executive producer, What’s Next Longevity Summit events; author of “Turning Silver into Gold: How to Profit in the New Boomer Marketplace”; Advisory Council, Centre for Aging + Brain Health Innovation; Advisory Board, Thrive Center.
- Ed. D., University of Southern California; BA, Holy Names University.
Maryam Saleh, PhD
Executive Director, Kaplan Institute for Innovation and Tech Entrepreneurship, Illinois Institute of Technology
- Recognized by Crain’s Chicago Tech 50 (2016) for leadership in tech
commercialization.
- VP Programs, MATTER; VP/GM, Sales & Partnerships, Machinify; Managing Director, Innovation & New Ventures Office, Northwestern University; Founding team, Cyberkinetics Neurotechnology Systems, commercializing brain implant technology.
- BSc Computer Engineering, Brown University; PhD Computational Neuroscience, University of Chicago.
Ruth Anne Eatock, PhD
Professor of Neurobiology and the Neuroscience Institute, University of Chicago
- Neuroscientist with expertise in sensing and processing of balance information by mechanosensory receptors and neurons of the vestibular organs in the inner ear.
- Research spans both normal functioning and potential for regeneration of damaged vestibular system components.
- BSc, MSc Neurobiology, Biology, McGill University; PhD Biology, Caltech; postdoctoral fellow, inner ear physiology, MIT and Massachusetts Eye and Ear Infirmary. Professor at Harvard University and Baylor College of Medicine.
Andreas Caduff, PhD
Health Tech Executive | Speaker | Advisor | Board Member
- Founder and CEO (2011-2019) at Biovotion (acquired by Biofourmis in 2019). Driving force in the development of non-invasive, wearable medical sensor technologies in the pharmaceutical and medical device industries.
- Enjoys working at the interface of secured wearable medical tech, physiological monitoring, and data science towards more holistic, user centric health offerings
- PhD Biophysics, The Hebrew University of Jerusalem. MSc Biotechnology, Teesside University. BSc Chemistry, ZHAW Zurich University of Applied Sciences.
Contact Us
Learn more about Neursantys R&D collaborations, pilot deployments, and employment opportunities.
Contact Us
